Current population · 2,231
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.
CRyPTIC Consortium and the 100,000 Genomes Project; Allix-Béguec C, Arandjelo...
← ExplorerSource ↗Publication identity
Publication IDCPD-1361
Year2018
PMID30280646
DOI10.1056/NEJMoa1800474
JournalNot recorded
AuthorsCRyPTIC Consortium and the 100,000 Genomes Project; Allix-Béguec C, Arandjelo...
First authorCRyPTIC Consortium and the 100
Senior authorZhu B.N Engl J Med.
Scientific classification
Research themeTuberculosis / mycobacteria; Genomics / bioinformatics
Pathogen groupMycobacterium tuberculosis complex
Technology / methodWhole-genome sequencing; Culture / phenotypic methods
Object stateOBSERVED
Provenance & boundary
Generated Passport: this is a derived view of the canonical publication object. Missing or unsupported information remains unfilled; no scientific interpretation or current-staff status is manufactured.
PopulationCIDM Publications · 2,231
Source statussource-derived / affiliation verification required
Investigator sourceSintchenko V
Canonical source URLhttps://pubmed.ncbi.nlm.nih.gov/30280646/
Author / Colleague Reality Return
Return corrections about identity, authorship, paper-specific CIDM/CIDM-PH affiliation, metadata, source/provenance, figure/table linkage, evidence boundary, or links.
Feedback → source check → evidence status → warranted correction → versioned update.
Open feedback route →